JP2026507086A5 - - Google Patents

Info

Publication number
JP2026507086A5
JP2026507086A5 JP2025549728A JP2025549728A JP2026507086A5 JP 2026507086 A5 JP2026507086 A5 JP 2026507086A5 JP 2025549728 A JP2025549728 A JP 2025549728A JP 2025549728 A JP2025549728 A JP 2025549728A JP 2026507086 A5 JP2026507086 A5 JP 2026507086A5
Authority
JP
Japan
Prior art keywords
glp
fusion protein
bispecific fusion
analog
diabetes
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2025549728A
Other languages
English (en)
Japanese (ja)
Other versions
JP2026507086A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2024/008655 external-priority patent/WO2024263005A1/ko
Publication of JP2026507086A publication Critical patent/JP2026507086A/ja
Publication of JP2026507086A5 publication Critical patent/JP2026507086A5/ja
Pending legal-status Critical Current

Links

JP2025549728A 2023-06-22 2024-06-21 新規な二重特異性融合タンパク質及びその用途 Pending JP2026507086A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2023008718 2023-06-22
KRPCT/KR2023/008718 2023-06-22
PCT/KR2024/008655 WO2024263005A1 (ko) 2023-06-22 2024-06-21 신규 이중 특이성 융합단백질 및 그의 용도

Publications (2)

Publication Number Publication Date
JP2026507086A JP2026507086A (ja) 2026-02-27
JP2026507086A5 true JP2026507086A5 (https=) 2026-03-31

Family

ID=93935935

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2025549728A Pending JP2026507086A (ja) 2023-06-22 2024-06-21 新規な二重特異性融合タンパク質及びその用途

Country Status (5)

Country Link
EP (1) EP4733314A1 (https=)
JP (1) JP2026507086A (https=)
CN (1) CN121358758A (https=)
AU (1) AU2024313859A1 (https=)
WO (1) WO2024263005A1 (https=)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20070115947A (ko) * 2005-02-11 2007-12-06 아밀린 파마슈티칼스, 인크. 선택가능한 특성들을 가지는 ｇｉｐ 유사체 및 하이브리드폴리펩타이드
ES2623925T3 (es) 2007-05-30 2017-07-12 Postech Academy-Industry- Foundation Proteínas de fusión de inmunoglobulina
KR101442254B1 (ko) 2008-02-22 2014-09-24 포항공과대학교 산학협력단 최적의 진핵 세포 발현 벡터의 개발
ES2610356T3 (es) 2009-02-03 2017-04-27 Amunix Operating Inc. Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos
KR101825048B1 (ko) * 2014-12-31 2018-02-05 주식회사 제넥신 GLP 및 면역글로불린 하이브리드 Fc 융합 폴리펩타이드 및 이의 용도
KR102349717B1 (ko) * 2020-03-12 2022-01-11 주식회사 에스엘메타젠 신규 대사증후군 및 그와 관련된 질환 치료용 약학 조성물
US20240368239A1 (en) * 2020-03-12 2024-11-07 Sl Metagen Novel bispecific protein and use thereof

Similar Documents

Publication Publication Date Title
JP6229038B2 (ja) 修飾された血管作動性腸管ペプチド
JP6084215B2 (ja) ポリエチレングリコールまたはその誘導体でｐｅｇ化されたエキセンジン−４類似体、その調製法、および活性成分としてこれを含有する、糖尿病を予防または処置するための薬学的組成物
JP7536030B2 (ja) 増殖分化因子１５併用療法
WO2021136303A1 (zh) 长效glp-1化合物
CA2434237A1 (en) Glp-1 fusion proteins
US11179440B2 (en) Pharmaceutical composition containing FGF21 mutant fusion protein and method for treating hepatitis, hepatic fibrosis, and hepatic cirrhosis
WO2008056726A1 (en) Glp-1 derivative and use thereof
JP2016511752A5 (https=)
JP2018515088A5 (https=)
RU2007119989A (ru) Композиции, слитые конструкции и конъюгаты plad домена
JP2023548945A5 (https=)
CA3241355A1 (en) Treatment using heterodimeric relaxin fusions
JP2017500316A5 (https=)
JP2026507086A5 (https=)
JP2024519950A (ja) Ｇｄｆ１５変異体及びｇｌｐ－１受容体作動薬を含む併用投与用組成物
AU2024246525A1 (en) Methods and uses for treating nausea and emesis
JP2022513626A5 (https=)
US11807672B2 (en) Conjugates of islet neogenesis peptides and analogs, and methods thereof
JP2026507086A (ja) 新規な二重特異性融合タンパク質及びその用途
HK40128194A (zh) 一种glp1/gdf15双重激动剂
RU2022104898A (ru) Слитый белок fgf21 fc, слитый белок glp-1 fc и комбинированный терапевтический агент, включающий их, и их применение
JP2025539794A (ja) 二重機能タンパク質およびその使用